Skip to main content
. 2022 Feb 22;10(3):520. doi: 10.3390/biomedicines10030520
AMPK AMP-activated protein kinase
ANTs anthracyclines
ARE antioxidant response element
BCL-2 B cell lymphoma-2
CHF chronic heart failure
CMDL-1 cardiomyocyte mitochondrial dynamic-related lncRNA 1
CML chronic myelogenous leukemia
CVAEs cardiovascular adverse events
CVDs cardiovascular diseases
DOX doxorubicin
Drp1 dynamin-related protein 1
ER endoplasmic reticulum
Fis1 fission protein 1
FoxO Forkhead box subgroup O
GPER G-protein coupled receptor 30
GSH glutathione
hiPSC-CM human-induced pluripotent stem cell-derived cardiomyocytes
I/R ischemia/reperfusion
IMM inner mitochondrial membrane
Keap1 kelch-like ECH-associated protein 1
LIR LC-3-interacting region
MAD mitochondria-associated degradation
MFF mitochondrial fission factor
MFN1 mitofusin-1
MFN2 mitofusin 2
Midivi-1 mitochondrial division inhibitor-1
MM multiple myeloma
mtDNA mitochondrial DNA
NFAT nuclear factor of activated T-cells
Nfe2l2 nuclear factor erythroid derived 2 like 2
Nrf2 nuclear factor erythroid 2–related factor 2
OMM outer mitochondrial membrane
OPA1 optic atrophy 1
PDK pyruvate dehydrogenase kinase
PGC-1α peroxisome proliferator-activated receptor gamma coactivator 1-α
PGC-1β peroxisome proliferator-activated receptor gamma coactivator 1-β
Ph+ B-ALL Philadelphia chromosome-positive B-acute lymphoblastic leukemia
PINK1 PTEN-induced putative kinase 1
PIs proteasome inhibitors
RNS reactive nitrogen species
ROS reactive oxygen species
RTKIs receptor tyrosine kinase inhibitors
RTKs Receptor tyrosine kinases
SOD superoxide dismutase
Top topoisomerase
TXNRD thioredoxin reductase
UBD ubiquitin binding domain
UCP-2 uncoupling protein 2
UCP-3 uncoupling protein 3
UPS ubiquitin–proteasome system
URPmt mitochondrial unfolded protein response
VEGF vascular endothelial growth factor